RPGLF (Regent Pacific Group) Financial Strength: 0 (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

RPGLF Regent Pacific Group Ltd RPGLF
14 GF Score
Price $0.01
! 7 Warning Signs
View Full Analysis

What is Regent Pacific Group Financial Strength?

Regent Pacific Group has the Financial Strength Rank of 0.

GuruFocus Financial Strength Rank measures how strong a company's financial situation is. It is rated on a scale of 1 to 10 and is based on these factors:

1. The debt burden that the company has as measured by its Interest Coverage (current year). The higher, the better.
2. Debt to revenue ratio. The lower, the better.
3. Altman Z-Score.
4. Other debt related ratios.

A higher score indicates a stronger financial position, with companies rated 7 or above considered financially stable and unlikely to face distress. Conversely, a score of 3 or below suggests potential financial difficulties, indicating a higher risk of distress.

Regent Pacific Group did not have earnings to cover the interest expense. Regent Pacific Group's debt to revenue ratio for the quarter that ended in Dec. 2025 was 15.63. As of today, Regent Pacific Group's Altman Z-Score is -809.19.


Regent Pacific Group  (OTCPK:RPGLF) Financial Strength Explanation

The rank is rated on a scale of 1 to 10. A higher score indicates a stronger financial position, with companies rated 7 or above considered financially stable and unlikely to face distress. Conversely, a score of 3 or below suggests potential financial difficulties, indicating a higher risk of distress.

Regent Pacific Group has the Financial Strength Rank of 0.


Regent Pacific Group Financial Strength Related Terms


RPGLF vs ZTS: Financial Strength Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Regent Pacific Group's Financial Strength, along with its competitors' market caps and Financial Strength data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Regent Pacific Group Financial Strength vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Regent Pacific Group's Financial Strength distribution charts can be found below:

* The bar in red indicates where Regent Pacific Group's Financial Strength falls into.


RPGLF
14GF Score
Regent Pacific Group Ltd RPGLF
Financial Strength is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Regent Pacific Group Financial Strength Calculation

GuruFocus Financial Strength Rank measures how strong a company's financial situation is. It is based on these factors

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

1. The debt burden that the company has as measured by its Interest Coverage (current year). The higher, the better.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:

Regent Pacific Group's Interest Expense for the months ended in Dec. 2025 was $-0.16 Mil. Its Operating Income for the months ended in Dec. 2025 was $-2.29 Mil. And its Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2025 was $0.01 Mil.

Regent Pacific Group's Interest Coverage for the quarter that ended in Dec. 2025 is

Regent Pacific Group did not have earnings to cover the interest expense.

The higher the ratio, the stronger the company's financial strength is.

2. Debt to revenue ratio. The lower, the better.

Regent Pacific Group's Debt to Revenue Ratio for the quarter that ended in Dec. 2025 is

Debt to Revenue Ratio=Total Debt (Q: Dec. 2025 ) / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(3.927 + 0.012) / 0.252
=15.63

3. Altman Z-Score.

Z-Score model is an accurate forecaster of failure up to two years prior to distress. It can be considered the assessment of the distress of industrial corporations.

The zones of discrimination were as such:

When Z-Score is less than 1.81, it is in Distress Zones.
When Z-Score is greater than 2.99, it is in Safe Zones.
When Z-Score is between 1.81 and 2.99, it is in Grey Zones.

Regent Pacific Group has a Z-score of -809.19, indicating it is in Distress Zones. This implies bankrupcy possibility in the next two years.

Warning Sign:

Altman Z-score of -809.19 is in distress zone. This implies bankruptcy possibility in the next two years.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Regent Pacific Group Business Description

Other Exchanges 00575:Hong KongRPG:Germany
Address 5 Queen\'s Road Central, 8th Floor, Henley Building, Hong Kong, HKG
Regent Pacific Group Ltd is an investment holding company that runs through two segments: Biopharma and Corporate Investment. Its Biopharma segment is engaged in the research, development, manufacturing, marketing, and sales of pharmaceutical products, and it also develops artificial intelligence (AI) systems for the field of biological aging clocks. The Corporate Investment segment is engaged in the investment in listed and unlisted corporate entities. The majority of its revenue comes from the Biopharma segment. Geographically, the Europe; U.S.; and Asia Pacific. It derives maximum revenue from Europe.
14GF Score

Get the complete analysis for RPGLF

Financial Strength is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.01
Price